Cytokeratine 5 (KRT5) (Basal, Myopethelial & Mesothelial Cell Marker)

[KRT5]

3852

Human

Store at 2 to 8 degree C.<br>Antibody is stable for 24 months. Non-hazardous. No MSDS required.

This MAb recognizes a protein of 58kDa, which is identified as Cytokeratin 5 (KRT5). This type II cytokeratin is specifically expressed in the basal layer of the epidermis with family member KRT14. Antibodies to KRT5 identify basal cells of squamous and glandular epithelia, myoepithelia, and mesothelium.Anti-cytokeratin 5 has been reported useful in the differential metastatic carcinoma in the pleura versus epithelioid mesothelioma. Almost all squamous cell carcinomas, half of transitional carcinomas, and many undifferentiated large cell carcinomas express.Anti-KRT5, along with anti-p63, affords a high sensitivity and specificity for squamous differentiation. Myoepithelial cells of the breast, glandular epithelia, and basal cells of the prostate are labeled with anti-KRT5.

[KRT5; KRT5; K5; CK5; DDD; DDD1; EBS2; KRT5A; CK-5; K5]

[Cytokeratin 5 (KRT5)]

[keratin, type II cytoskeletal 5; Keratin, type II cytoskeletal 5; keratin, type II cytoskeletal 5; keratin 5; 58 kDa cytokeratin; Cytokeratin-5; CK-5; Keratin-5; K5; Type-II keratin Kb5]

119395754

NP_000415.2

NP_000415.2

P13647